Stock Events
Stock Events
Features
Business
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Larimar Therapeutics (ZA71.STU) Q1 2026 Earnings
ZA71.STU
19
Mar
Confirmed
Q1 2026
-0.63
-0.56
-0.49
-0.42
Details
Expected EPS
-0.42267519015
Actual EPS
-0.6305813
Surprise EPS
-0.21
Surprise Percent
+49.19%
Description
Larimar Therapeutics (ZA71.STU) has reported earnings of -0.6305813 per share for Q1 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login
Home
Timeline
Search
Watchlist